Xeomin - 0259-1605-01 - (incobotulinumtoxinA)

Alphabetical Index


Drug Information of Xeomin

Product NDC: 0259-1605
Proprietary Name: Xeomin
Non Proprietary Name: incobotulinumtoxinA
Active Ingredient(s): 50    [USP'U]/1 & nbsp;   incobotulinumtoxinA
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Xeomin

Product NDC: 0259-1605
Labeler Name: Merz Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125360
Marketing Category: BLA
Start Marketing Date: 20100901

Package Information of Xeomin

Package NDC: 0259-1605-01
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (0259-1605-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE

NDC Information of Xeomin

NDC Code 0259-1605-01
Proprietary Name Xeomin
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (0259-1605-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Product NDC 0259-1605
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name incobotulinumtoxinA
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAMUSCULAR
Start Marketing Date 20100901
Marketing Category Name BLA
Labeler Name Merz Pharmaceuticals, LLC
Substance Name BOTULINUM TOXIN TYPE A
Strength Number 50
Strength Unit [USP'U]/1
Pharmaceutical Classes Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]

Complete Information of Xeomin


General Information